Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PBMs Offering Prescribers Real Time Visibility On Cost-Sharing, Cheaper Alternatives

Executive Summary

CVS Health and OptumRx join Express Scripts in offering programs to enhance transparency around prescription drug cost sharing, reinforcing the impact of formulary placement.

You may also be interested in...



CVS ‘Guaranteed Net Cost’ Program Is Alternative To High Price/High Rebate Model

Program likely to generate fewer rebates so it remains to be seen whether payers will embrace the new model in a big way.

CVS Sees Growing Physician, Patient Use Of Real-Time Drug Price Data

Prescribers are reviewing patient benefits information nearly 280,000 times per week while patients are using an online Check Drug Cost tool 250,000 times per month – and the numbers are growing.

UnitedHealthcare Will Apply About 80% Of Rebates At Point-Of-Sale

Insurer offers additional details on upcoming rebate program, including how it will protect contract confidentiality, and which members might use it the most.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

PS122935

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel